tiprankstipranks
Argenx Se (ARGX)
NASDAQ:ARGX
US Market
ARGX
Argenx Se
RESEARCH TOOLSreports
Want to see ARGX full AI Analyst Report?

Argenx Se (ARGX) Stock Forecast & Price Target

810 Followers
See the Price Targets and Ratings of:

ARGX Analyst Ratings

Strong Buy
19Ratings
Strong Buy
17 Buy
2 Hold
0 Sell
Based on 19 analysts giving stock ratings to
Argenx
Se
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ARGX Stock 12 Month Forecast

Average Price Target

$1,015.01
▲(19.55% Upside)
Based on 19 Wall Street analysts offering 12 month price targets for Argenx Se in the last 3 months. The average price target is $1,015.01 with a high forecast of $1,260.00 and a low forecast of $782.17. The average price target represents a 19.55% change from the last price of $849.04.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"541":"$541","721":"$721","901":"$901","1081":"$1,081","1261":"$1,261"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1260,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.26K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1015.0094444444444,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.02K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":782.17,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$782.17</span>\n  </div></div>","useHTML":true}}],"tickPositions":[541,721,901,1081,1261],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,783.5,820.1538461538462,856.8076923076923,893.4615384615385,930.1153846153846,966.7692307692307,1003.4230769230769,1040.076923076923,1076.7307692307693,1113.3846153846152,1150.0384615384614,1186.6923076923076,1223.3461538461538,{"y":1260,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,783.5,801.3084188034188,819.1168376068376,836.9252564102565,854.7336752136752,872.542094017094,890.3505128205128,908.1589316239316,925.9673504273504,943.7757692307691,961.584188034188,979.3926068376068,997.2010256410256,{"y":1015.0094444444444,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,783.5,783.3976923076923,783.2953846153846,783.1930769230769,783.0907692307692,782.9884615384615,782.8861538461538,782.7838461538462,782.6815384615385,782.5792307692308,782.4769230769231,782.3746153846154,782.2723076923077,{"y":782.17,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":639.9,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 50,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":584.605,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 53,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":542.47,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":673.8,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":706.41,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":767.33,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 52,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":818.5,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":894.9,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":840.95,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":835.68,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":756.76,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":743.12,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":783.5,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$1,260Average Price Target$1,015Lowest Price Target$782.17
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on ARGX
Tazeen Ahmad
Bank of America Securities
Bank of America Securities
$1,016
Buy
19.66%
Upside
Reiterated
05/12/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Citi Analyst forecast on ARGX
Samantha Semenkow
Citi
Citi
$1,152
Buy
35.68%
Upside
Reiterated
05/12/26
Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX), Siemens Healthineers AG (Other OTC: SEMHF) and BioNTech SE (NASDAQ: BNTX)
William Blair Analyst forecast on ARGX
Myles Minter
William Blair
William Blair
―
Buy
―
Reiterated
05/11/26
Myles Minter Reiterates Buy as Vyvgart’s Expanded FDA Label and Attractive Valuation Support Continued Growth
TD Cowen Analyst forecast on ARGX
Yaron Werber
TD Cowen
TD Cowen
$1,146→$782.17
Buy
-7.88%
Downside
Reiterated
05/11/26
Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Protagonist Therapeutics (PTGX)
Piper Sandler Analyst forecast on ARGX
Allison Bratzel
Piper Sandler
Piper Sandler
$1,075
Buy
26.61%
Upside
Reiterated
05/11/26
Piper Sandler Sticks to Its Buy Rating for Argenx Se (ARGX)
H.C. Wainwright Analyst forecast on ARGX
Douglas Tsao
H.C. Wainwright
H.C. Wainwright
$940
Buy
10.71%
Upside
Reiterated
05/11/26
H.C. Wainwright Sticks to Their Buy Rating for Argenx Se (ARGX)
Truist Financial Analyst forecast on ARGX
Danielle Brill
Truist Financial
Truist Financial
$1,030
Buy
21.31%
Upside
Reiterated
05/11/26
Truist Financial Sticks to Its Buy Rating for Argenx Se (ARGX)
Jefferies Analyst forecast on ARGX
Unknown Analyst
Jefferies
Not Ranked
Jefferies
$1,008→$1,013
Buy
19.31%
Upside
Reiterated
05/08/26
Argenx Se (ARGX) Receives a Buy from Jefferies
Wells Fargo Analyst forecast on ARGX
Derek Archila
Wells Fargo
Wells Fargo
$1,247→$1,260
Buy
48.40%
Upside
Reiterated
05/08/26
Argenx price target raised to $1,260 from $1,247 at Wells FargoArgenx price target raised to $1,260 from $1,247 at Wells Fargo
Wedbush Analyst forecast on ARGX
David Nierengarten
Wedbush
Wedbush
$1,000
Buy
17.78%
Upside
Reiterated
05/08/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Morgan Stanley Analyst forecast on ARGX
Sean Laaman
Morgan Stanley
Morgan Stanley
$1,230→$1,170
Buy
37.80%
Upside
Reiterated
05/08/26
Argenx price target lowered to $1,170 from $1,230 at Morgan StanleyArgenx price target lowered to $1,170 from $1,230 at Morgan Stanley
UBS Analyst forecast on ARGX
Xian Deng
UBS
UBS
$850
Hold
0.11%
Upside
Reiterated
05/08/26
Analysts Offer Insights on Healthcare Companies: Alcon (NYSE: ALC), Argenx Se (NASDAQ: ARGX) and Definium Therapeutics (NASDAQ: DFTX)
Stifel Nicolaus Analyst forecast on ARGX
Alex Thompson CFA
Stifel Nicolaus
Stifel Nicolaus
$1,227→$1,222
Buy
43.93%
Upside
Reiterated
05/07/26
Analysts' Top Healthcare Picks: Argenx Se (ARGX), Pharming Group (PHAR)
Guggenheim Analyst forecast on ARGX
Yatin Suneja
Guggenheim
Guggenheim
$1,120→$1,135
Buy
33.68%
Upside
Reiterated
05/07/26
Argenx price target raised to $1,135 from $1,120 at GuggenheimArgenx price target raised to $1,135 from $1,120 at Guggenheim
RBC Capital Analyst forecast on ARGX
Luca Issi
RBC Capital
RBC Capital
$890
Buy
4.82%
Upside
Reiterated
05/07/26
RBC Capital Sticks to Their Buy Rating for Argenx Se (ARGX)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on ARGX
Tazeen Ahmad
Bank of America Securities
Bank of America Securities
$1,016
Buy
19.66%
Upside
Reiterated
05/12/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Citi Analyst forecast on ARGX
Samantha Semenkow
Citi
Citi
$1,152
Buy
35.68%
Upside
Reiterated
05/12/26
Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX), Siemens Healthineers AG (Other OTC: SEMHF) and BioNTech SE (NASDAQ: BNTX)
William Blair Analyst forecast on ARGX
Myles Minter
William Blair
William Blair
―
Buy
―
Reiterated
05/11/26
Myles Minter Reiterates Buy as Vyvgart’s Expanded FDA Label and Attractive Valuation Support Continued Growth
TD Cowen Analyst forecast on ARGX
Yaron Werber
TD Cowen
TD Cowen
$1,146→$782.17
Buy
-7.88%
Downside
Reiterated
05/11/26
Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Protagonist Therapeutics (PTGX)
Piper Sandler Analyst forecast on ARGX
Allison Bratzel
Piper Sandler
Piper Sandler
$1,075
Buy
26.61%
Upside
Reiterated
05/11/26
Piper Sandler Sticks to Its Buy Rating for Argenx Se (ARGX)
H.C. Wainwright Analyst forecast on ARGX
Douglas Tsao
H.C. Wainwright
H.C. Wainwright
$940
Buy
10.71%
Upside
Reiterated
05/11/26
H.C. Wainwright Sticks to Their Buy Rating for Argenx Se (ARGX)
Truist Financial Analyst forecast on ARGX
Danielle Brill
Truist Financial
Truist Financial
$1,030
Buy
21.31%
Upside
Reiterated
05/11/26
Truist Financial Sticks to Its Buy Rating for Argenx Se (ARGX)
Jefferies Analyst forecast on ARGX
Unknown Analyst
Jefferies
Not Ranked
Jefferies
$1,008→$1,013
Buy
19.31%
Upside
Reiterated
05/08/26
Argenx Se (ARGX) Receives a Buy from Jefferies
Wells Fargo Analyst forecast on ARGX
Derek Archila
Wells Fargo
Wells Fargo
$1,247→$1,260
Buy
48.40%
Upside
Reiterated
05/08/26
Argenx price target raised to $1,260 from $1,247 at Wells FargoArgenx price target raised to $1,260 from $1,247 at Wells Fargo
Wedbush Analyst forecast on ARGX
David Nierengarten
Wedbush
Wedbush
$1,000
Buy
17.78%
Upside
Reiterated
05/08/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Morgan Stanley Analyst forecast on ARGX
Sean Laaman
Morgan Stanley
Morgan Stanley
$1,230→$1,170
Buy
37.80%
Upside
Reiterated
05/08/26
Argenx price target lowered to $1,170 from $1,230 at Morgan StanleyArgenx price target lowered to $1,170 from $1,230 at Morgan Stanley
UBS Analyst forecast on ARGX
Xian Deng
UBS
UBS
$850
Hold
0.11%
Upside
Reiterated
05/08/26
Analysts Offer Insights on Healthcare Companies: Alcon (NYSE: ALC), Argenx Se (NASDAQ: ARGX) and Definium Therapeutics (NASDAQ: DFTX)
Stifel Nicolaus Analyst forecast on ARGX
Alex Thompson CFA
Stifel Nicolaus
Stifel Nicolaus
$1,227→$1,222
Buy
43.93%
Upside
Reiterated
05/07/26
Analysts' Top Healthcare Picks: Argenx Se (ARGX), Pharming Group (PHAR)
Guggenheim Analyst forecast on ARGX
Yatin Suneja
Guggenheim
Guggenheim
$1,120→$1,135
Buy
33.68%
Upside
Reiterated
05/07/26
Argenx price target raised to $1,135 from $1,120 at GuggenheimArgenx price target raised to $1,135 from $1,120 at Guggenheim
RBC Capital Analyst forecast on ARGX
Luca Issi
RBC Capital
RBC Capital
$890
Buy
4.82%
Upside
Reiterated
05/07/26
RBC Capital Sticks to Their Buy Rating for Argenx Se (ARGX)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Argenx Se

3 Months
xxx
Success Rate
15/19 ratings generated profit
79%
Average Return
+6.68%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 78.95% of your transactions generating a profit, with an average return of +6.68% per trade.
1 Year
Thomas SmithLeerink Partners
Success Rate
25/27 ratings generated profit
93%
Average Return
+30.54%
Copying Thomas Smith's trades and holding each position for 1 Year would result in 92.59% of your transactions generating a profit, with an average return of +30.54% per trade.
2 Years
xxx
Success Rate
27/27 ratings generated profit
100%
Average Return
+60.73%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +60.73% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ARGX Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
2
5
6
5
4
Buy
37
44
33
24
28
Hold
5
5
3
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
44
54
42
32
35
In the current month, ARGX has received 32 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. ARGX average Analyst price target in the past 3 months is 1,015.01.
Each month's total comprises the sum of three months' worth of ratings.

ARGX Financial Forecast

ARGX Earnings Forecast

Next quarter’s earnings estimate for ARGX is $6.38 with a range of $5.22 to $7.85. The previous quarter’s EPS was $5.52. ARGX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ARGX has Performed in-line its overall industry.
Next quarter’s earnings estimate for ARGX is $6.38 with a range of $5.22 to $7.85. The previous quarter’s EPS was $5.52. ARGX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ARGX has Performed in-line its overall industry.

ARGX Sales Forecast

Next quarter’s sales forecast for ARGX is $1.44B with a range of $1.40B to $1.51B. The previous quarter’s sales results were $1.30B. ARGX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ARGX has Performed in-line its overall industry.
Next quarter’s sales forecast for ARGX is $1.44B with a range of $1.40B to $1.51B. The previous quarter’s sales results were $1.30B. ARGX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ARGX has Performed in-line its overall industry.

ARGX Stock Forecast FAQ

What is ARGX’s average 12-month price target, according to analysts?
Based on analyst ratings, Argenx Se’s 12-month average price target is 1,015.01.
    What is ARGX’s upside potential, based on the analysts’ average price target?
    Argenx Se has 19.55% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ARGX a Buy, Sell or Hold?
          Argenx Se has a consensus rating of Strong Buy which is based on 17 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Argenx Se’s price target?
            The average price target for Argenx Se is 1,015.01. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $1,260.00 ,the lowest forecast is $782.17. The average price target represents 19.55% Increase from the current price of $849.04.
              What do analysts say about Argenx Se?
              Argenx Se’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.
                How can I buy shares of ARGX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.